Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
A Yale University-sponsored clinical trial is exploring the pathogenesis of pediatric nonalcoholic fatty liver disease and is currently recr…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults [NA]
This clinical trial investigates whether orange peel fermentation can reduce body fat in adults who are overweight, including those with fat…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH [Phase 2]
A Phase 2 trial is evaluating ASC41 tablets for safety, tolerability, and efficacy in adults with nonalcoholic fatty liver disease and nonal…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Radiological Spectrum Of Fatty Liver Correlate With High Resolution Ultrasonography Of Fibrosis And Cirrhosis
Clinical trial update examining how high-resolution ultrasound findings correlate with fibrosis and cirrhosis in fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: De Novo Lipogenesis in Severity of NAFLD
A completed clinical trial from the University of Missouri-Columbia investigates the role of de novo lipogenesis in the severity of nonalcoh…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: The Liver Health Study for Patients with NAFLD [NA]
Clinical trial record describing the Liver Health Study for patients with nonalcoholic fatty liver disease, including nonalcoholic steatohep…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease
A clinical trial update notes the evaluation of sodium-glucose cotransporter-2 inhibitors for non-alcoholic fatty liver disease, with the st…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 is a recruiting epidemiological clinical trial at Osaka Metropolitan Univer…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance [NA]
Stanford University is conducting a longitudinal multi-omic study to uncover mechanisms of obesity-mediated insulin resistance, with recruit…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients with Nonalcoholic Fatty Liver Disease [NA]
Clinical trial entry describing a study on the effects of phytosterol supplementation on liver function and inflammatory status in patients …
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: The Effect of Time-restricted Eating on Liver Metabolism [NA]
The clinical trial evaluating the effect of time-restricted eating on liver metabolism has completed, studying nonalcoholic fatty liver dise…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference
This completed clinical trial compared magnetic resonance elastography (MRE) and corrected-T1 (cT1) for diagnosing fibrosis and inflammation…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans [EARLY_Phase 1]
An early-phase trial found that raspberry ketone intake upregulates circulating FGF21 and increases energy expenditure in humans, with obesi…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
This document provides an update on the development of new non-invasive biomarkers for metabolic dysfunction-associated steatotic liver dise…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD
This document reports a clinical trial update on developing a novel Asian Mediterranean diet and assessing its acceptability in nonalcoholic…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis [Phase 2]
A Phase 2 trial update reports results for saroglitazar magnesium in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Resu…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD) [Phase 2]
Phase 2 trial evaluating saroglitazar 4 mg in liver transplant recipients with nonalcoholic fatty liver disease (NAFLD) to assess safety, to…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)
A clinical trial protocol evaluating integrated phenotyping of the gut-platelet-liver axis to understand progression of chronic liver diseas…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial update reporting on the efficacy and safety of pemafibrate for nonalcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects [Phase 1]
Completed Phase 1 trial evaluating the safety and initial efficacy of ASC41 in overweight and obese subjects, including participants with NA…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial of lanifibranor in patients with nonalcoholic fatty liver disease and type 2 diabetes completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) [Phase 2]
Phase 2 study assessing the pharmacokinetics of NRL972 in patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ha…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.
A clinical trial update investigates the role of the protein plin5 in the development of nonalcoholic fatty liver disease.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Lifestyle Changes in Fatty Liver; Additive Effect of Honey Intake [NA]
A Cairo University clinical trial is exploring lifestyle changes and the additive effect of honey intake on nonalcoholic fatty liver disease…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients at Assiut University Hospital
A clinical trial at Assiut University Hospital is examining nonalcoholic fatty liver disease and liver fibrosis in patients with systemic lu…